1. |
朱晓芸, 马如超, 于红刚. 我国内镜黏膜下剥离术与外科手术治疗早期胃癌疗效 Meta 分析. 中华肿瘤防治杂志, 2019, 26(17): 1296-1305.
|
2. |
苏昭然, 王贤, 束宽山, 等. 胃镜活检病理为高级别上皮内瘤变的外科精准治疗. 中国普通外科杂志, 2018, 27(4): 401-407.
|
3. |
计小刚, 冯永江. 腹腔镜 D2 根治术与传统开腹术治疗胃癌的近期及远期临床疗效比较. 中国普通外科杂志, 2014, 23(4): 547-550.
|
4. |
周家琛, 郑荣寿, 庄贵华, 等. 2000–2015 年中国肿瘤登记地区胃癌发病趋势及年龄变化. 实用肿瘤学杂志, 2020, 34(1): 1-5.
|
5. |
赵娥, 孙高峰, 谢惠芳. 2016、2017 年乌鲁木齐市胃癌流行病学特征分析. 预防医学论坛, 2018, 24(12): 881-884.
|
6. |
Qiu MZ, Zhou YX, Zhang XK, et al. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients. BMC Cancer, 2014, 14: 823.
|
7. |
Kerkar SP, Kemp CD, Duffy A, et al. The GYMSSA trial: A prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone. Trials, 2009, 10: 121.
|
8. |
薛侃, 李子禹, 李双喜, 等. 腹腔镜热灌注化疗联合腹腔及系统化疗转化治疗胃癌腹膜转移 1 例报告. 中国实用外科杂志, 2017, 37(10): 1135-1138.
|
9. |
甘强均, 张启, 李豪杰, 等. 晚期胃癌转化治疗后手术切除 13 例疗效分析. 中国实用外科杂志, 2017, 37(10): 1139-1142.
|
10. |
Amin MB, Edge SB, Greene FL, et al. AJCC Cancer Staging Manual. 8th ed. New York: Springer, 2016: 203-220.
|
11. |
Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer, 1994, 73(11): 2680-2686.
|
12. |
Fujitani K, Yang HK, Kurokawa Y, et al. Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01. Jpn J Clin Oncol, 2008, 38(7): 504-506.
|
13. |
Wilke H, Preusser P, Fink U, et al. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: A phase Ⅱ study with etoposide, doxorubicin, and cisplatin. J Clin Oncol, 1989, 7(9): 1318-1326.
|
14. |
Sym SJ, Chang HM, Ryu MH, et al. Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer. Ann Surg Oncol, 2010, 17(4): 1024-1032.
|
15. |
段新星, 淦锦, 张开华, 等. 新辅助腹腔内联合全身化疗对胃癌晚期腹膜转移的疗效探讨. 中国医学创新, 2019, 16(25): 21-25.
|
16. |
邹兵兵, 余昌俊, 章含昀, 等. 胃癌肝转移化疗转化手术治疗的临床效果. 安徽医学, 2018, 39(7): 800-804.
|
17. |
胡时栋, 邹贵军, 邹振玉, 等. 术前化疗对晚期胃癌患者 R0 切除的影响. 临床外科杂志, 2017, 25(2): 131-134.
|
18. |
熊金芹, 张帆, 王卫星. 阿帕替尼联合替吉奥治疗 TACE 术后的原发性肝癌的临床研究. 中国医院药学杂志, 2019, 39(18): 1876-1880.
|
19. |
李薇. 冷循环微波消融联合肝动脉栓塞化疗 (TACE) 治疗原发性肝癌的效果研究. 吉林医学, 2019, 40(9): 1987-1988.
|
20. |
朱亚军. 奥沙利铂、阿帕替尼、卡培他滨联合治疗晚期胃癌的疗效及安全性. 临床合理用药杂志, 2019, 12(23): 60-61.
|
21. |
宁泽, 陈睿, 陈柯宏, 等. 单用吉奥及阿帕替尼二线治疗晚期胃癌伴肝转移临床对比研究. 临床药物治疗杂志, 2019, 17(8): 61-65.
|